menu search

Aquestive therapeutics reaches agreement to extend principal payments due under credit facility to march 30, 2023 and receives bridge waiver of principal debt payment in advance of concluding formal a

WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commer...

October 6, 2021, 5:59 pm

Aquestive therapeutics reaches agreement to extend principal payments due under credit facility to march 30, 2023 and receives bridge waiver of principal debt payment in advance of concluding formal a

WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commer...

October 6, 2021, 5:59 pm

Aquestive therapeutics reaches agreement to extend principal payments due under credit facility to march 30, 2023 and receives bridge waiver of principal debt payment in advance of concluding formal a

WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commer...

October 6, 2021, 5:59 pm

Aquestive therapeutics reaches agreement to extend principal payments due under credit facility to march 30, 2023 and receives bridge waiver of principal debt payment in advance of concluding formal a

WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commer...

October 6, 2021, 5:59 pm

Orasure wins $109m contract to increase covid-19 test manufacturing capacity

OraSure Technologies Inc (NASDAQ: OSUR) has secured a $109 million contract from the U.S. Department of Defense to build additional manufacturing c...

October 4, 2021, 3:39 pm

Orasure wins $109m contract to increase covid-19 test manufacturing capacity

OraSure Technologies Inc (NASDAQ: OSUR) has secured a $109 million contract from the U.S. Department of Defense to build additional manufacturing c...

October 4, 2021, 3:39 pm

Orasure wins $109m contract to increase covid-19 test manufacturing capacity

OraSure Technologies Inc (NASDAQ: OSUR) has secured a $109 million contract from the U.S. Department of Defense to build additional manufacturing c...

October 4, 2021, 3:39 pm

Orasure wins $109m contract to increase covid-19 test manufacturing capacity

OraSure Technologies Inc (NASDAQ: OSUR) has secured a $109 million contract from the U.S. Department of Defense to build additional manufacturing c...

October 4, 2021, 3:39 pm

Orasure wins $109m contract to increase covid-19 test manufacturing capacity

OraSure Technologies Inc (NASDAQ: OSUR) has secured a $109 million contract from the U.S. Department of Defense to build additional manufacturing c...

October 4, 2021, 3:39 pm

Orasure wins $109m contract to increase covid-19 test manufacturing capacity

OraSure Technologies Inc (NASDAQ: OSUR) has secured a $109 million contract from the U.S. Department of Defense to build additional manufacturing c...

October 4, 2021, 3:39 pm

Orasure wins $109m contract to increase covid-19 test manufacturing capacity

OraSure Technologies Inc (NASDAQ: OSUR) has secured a $109 million contract from the U.S. Department of Defense to build additional manufacturing c...

October 4, 2021, 3:39 pm


Search within

Pages Search Results: